Skip to main content

HART Appoints Laura Mondano as Vice President of Regulatory Affairs To Lead HART’s 2016 IND Submission For its Bioengineered Organ Implant Solutions

Harvard Apparatus Regenerative Technology (Nasdaq: HART), a biotechnology company developing bioengineered organ implants for life-threatening conditions of the esophagus, trachea and bronchus, announced today that Laura Mondano has joined the company as Vice President of Regulatory Affairs, a new position at HART
http://www.prnewswire.com/news-releases/hart-appoints-laura-mondano-as-vice-president-of-regulatory-affairs-to-lead-harts-2016-ind-submission-for-its-bioengineered-organ-implant-solutions-300229895.html

No Comments yet!

Your Email address will not be published.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2022 Esophageal Cancer Education Foundation- by domino